Biotech

News, research & analysis from the global Biotechnology industry.

November 29, 2016

Promising Autologous CAR-T Cell Therapies Stumble: is this the End, or Just the Beginning?

[vc_row][vc_column][vc_column_text]The field of CAR-T immunotherapy presents a tantalising idea: reengineering a patient’s immune cells to attack cancer. CAR-T immunotherapy has the potential to revolutionise the way […]
November 9, 2016

Blood of Their Blood: Young Blood Transfusions & The Business of Ageing

[vc_row][vc_column][vc_column_text]The idea of transfusing blood from younger individuals to older individuals has returned to the spotlight following the commencement of clinical trials by US companies Alkahest […]
September 14, 2016

Cancer Immunotherapy: A Developmental Timeline & Examination of the Prior Art Paradox

[vc_row][vc_column][vc_column_text]The American Society of Clinical Oncology (ASCO) recently named cancer immunotherapy as the 2016 Advance of the Year, with President Dr. Julie Vose noting that “no […]
August 23, 2016

Pfizer to Buy Medivation for $14 Billion, But Who Are the Real Winners?

Pharmaceutical giants Pfizer are expanding their cancer portfolio through the $14B acquisition of California-based biopharmaceutical company Medivation. The acquisition follows two recent unsuccessful bids for Medivation […]